Status:

TERMINATED

Evaluating the Effectiveness of Telemonitoring System in the Management of Patients With CIDP

Lead Sponsor:

CSL Behring

Conditions:

Chronic Inflammatory Demyelinating Polyneuropathy

Eligibility:

All Genders

Brief Summary

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a chronic demyelinating polyneuropathy of autoimmune origin with a progressive or relapsing course. Diagnosis is based on clinical presenta...

Eligibility Criteria

Inclusion

  • Patient with a diagnosis of CIDP as per EFNS/PNS criteria.
  • Patient already receiving home-based treatment with Privigen®

Exclusion

  • Not applicable

Key Trial Info

Start Date :

November 27 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 3 2019

Estimated Enrollment :

11 Patients enrolled

Trial Details

Trial ID

NCT03779828

Start Date

November 27 2017

End Date

June 3 2019

Last Update

January 15 2021

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

Hôpital Pellegrin, Bordeaux University Hospital (CHU)

Bordeaux, France

2

Hôpital Henri Mondor - APHP

Créteil, France

3

Hôpital Roger Salengro - CHRU

Lille, France

4

Hôpital Pierre Wertheimer - HCL

Lyon, France